Pharma-Bio Serv Q1 revenue $2.3M, net income $32,860

Pharma-Bio Serv, Inc.

2026-Q1 EPS reported $0.00 revenue$2,294,966

Revenue of approx. $2.3M, down ~$0.2M from prior year quarter.
Net income of $32,860, an improvement of $24,324 compared to net loss in same quarter last year.
CEO cites improved operational efficiency and disciplined cost management.
Company focuses on sharpening service portfolio and concentrating on highest-value markets.

item 2.02 item 9.01

Key facts

Extracted from this filing and checked against the source text.

Earnings Releases SEC 8-K Item 2.02 confidence 0.95

Pharma-Bio Serv, Inc. reported quarter ended January 31, 2026 results: revenue approximately $2.3 million, net income $32,860.

Period: quarter ended January 31, 2026
Revenue: approximately $2.3 million
Net income: $32,860
Result: reported results

Exact text from the filing

biotechnology, chemical, medical device, cosmetic, food and allied products industries, today announced that revenues for the quarter ended January 31, 2026 were approximately $2.3 million, a decrease of approximately $0.2 million when compared to the same period last year. Net income for the quarter ended January 31, 2026 was $32,860, an improvement of $24,324

View on SEC.gov

308 earnings releases filed in the last 30 days. Browse all earnings releases →

Pharma-Bio Serv, Inc. filing history →

Source: SEC EDGAR

accession 0001654954-26-002338

view filing index on sec.gov

view primary document

Machine-readable: JSON · Markdown · Plain text

This headline and bullets were generated automatically by deepseek-v4-flash:cloud@v2 from the public filing. Read the source on SEC.gov before relying on any specific claim. Not investment advice. See methodology for how this pipeline works.